BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31269507)

  • 1. Common Genetic Variants in the Complement System and their Potential Link with Disease Susceptibility and Outcome of Invasive Bacterial Infection.
    van den Broek B; van der Flier M; de Groot R; de Jonge MI; Langereis JD
    J Innate Immun; 2020; 12(2):131-141. PubMed ID: 31269507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis.
    Brouwer MC; de Gans J; Heckenberg SG; Zwinderman AH; van der Poll T; van de Beek D
    Lancet Infect Dis; 2009 Jan; 9(1):31-44. PubMed ID: 19036641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Neisseria meningitidis and the complement system.
    Schneider MC; Exley RM; Ram S; Sim RB; Tang CM
    Trends Microbiol; 2007 May; 15(5):233-40. PubMed ID: 17398100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective potency of recombinant meningococcal IgA1 protease and its structural derivatives upon animal invasion with meningococcal and pneumococcal infections.
    Kotelnikova O; Alliluev A; Zinchenko A; Zhigis L; Prokopenko Y; Nokel E; Razgulyaeva O; Zueva V; Tokarskaya M; Yastrebova N; Gordeeva E; Melikhova T; Kaliberda E; Rumsh L
    Microbes Infect; 2019; 21(7):336-340. PubMed ID: 30797878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.
    Kugelberg E; Gollan B; Tang CM
    Vaccine; 2008 Dec; 26 Suppl 8(6):I34-9. PubMed ID: 19388162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human genetics of meningococcal infections.
    Hodeib S; Herberg JA; Levin M; Sancho-Shimizu V
    Hum Genet; 2020 Jun; 139(6-7):961-980. PubMed ID: 32067109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections of people with complement deficiencies and patients who have undergone splenectomy.
    Ram S; Lewis LA; Rice PA
    Clin Microbiol Rev; 2010 Oct; 23(4):740-80. PubMed ID: 20930072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of CRM₁₉₇ conjugated 9-valent pneumococcal and meningococcal C combination vaccine in healthy infants.
    Mallet E; Brachet E; Fernsten P; Laudat F; Razmpour A; Gruber WC;
    Vaccine; 2011 Aug; 29(34):5812-9. PubMed ID: 21296118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a C1s Inhibitor on the Efficacy of Anti-Capsular Antibodies against
    Lewis LA; Panicker S; DeOliveira RB; Parry GC; Ram S
    Immunohorizons; 2019 Nov; 3(11):519-530. PubMed ID: 31690560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease.
    Davila S; Wright VJ; Khor CC; Sim KS; Binder A; Breunis WB; Inwald D; Nadel S; Betts H; Carrol ED; de Groot R; Hermans PW; Hazelzet J; Emonts M; Lim CC; Kuijpers TW; Martinon-Torres F; Salas A; Zenz W; Levin M; Hibberd ML;
    Nat Genet; 2010 Sep; 42(9):772-6. PubMed ID: 20694013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms.
    Lewis LA; Ram S
    FEBS Lett; 2020 Aug; 594(16):2670-2694. PubMed ID: 32058583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR2-TLR4/CD14 polymorphisms and predisposition to severe invasive infections by Neisseria meningitidis and Streptococcus pneumoniae.
    Tellería-Orriols JJ; García-Salido A; Varillas D; Serrano-González A; Casado-Flores J
    Med Intensiva; 2014; 38(6):356-62. PubMed ID: 24144680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants.
    Yeh SH; Zangwill KM; Lee H; Chang SJ; Wong VI; Greenberg DP; Ward JI
    Vaccine; 2003 Jun; 21(19-20):2627-31. PubMed ID: 12744899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of complement in anti-bacterial defence.
    D'Amelio R; Biselli R
    Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
    Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bench-to-bedside review: genetic influences on meningococcal disease.
    Vermont CL; de Groot R; Hazelzet JA
    Crit Care; 2002 Feb; 6(1):60-5. PubMed ID: 11940267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human resistance to generalized bacterial infections (exemplified by meningococcal infection)].
    Platonov AE
    Vestn Ross Akad Med Nauk; 1999; (5):40-5. PubMed ID: 10394300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD46 accelerates macrophage-mediated host susceptibility to meningococcal sepsis in a murine model.
    Wang X; Zhang D; Sjölinder M; Wan Y; Sjölinder H
    Eur J Immunol; 2017 Jan; 47(1):119-130. PubMed ID: 27794168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections.
    Sprong T; Roos D; Weemaes C; Neeleman C; Geesing CL; Mollnes TE; van Deuren M
    Blood; 2006 Jun; 107(12):4865-70. PubMed ID: 16527897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.